Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196.SS)
CNY 26.05
(0.35%)
CNY 26.05
(0.35%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 4.36 Billion | 4.21 Billion | 3.94 Billion | 2.57 Billion | 3.22 Billion | 2.95 Billion |
| Net Income | 2.38 Billion | 3.94 Billion | 4.98 Billion | 3.93 Billion | 3.74 Billion | 3.01 Billion |
| Depreciation & Amortization | 3.11 Billion | 2.33 Billion | 1.83 Billion | 1.66 Billion | 1.47 Billion | 1.32 Billion |
| Deferred income taxes | -144.6 Million | -188.49 Million | -4.03 Billion | -2.6 Billion | -2.73 Billion | -1.87 Billion |
| Stock-based compensation | 35.89 Million | 54.48 Million | 64.28 Million | 55.21 Million | 109.06 Million | 72.32 Million |
| Change in working capital | -936.58 Million | -1.38 Billion | 259.74 Million | -1.4 Billion | -494.57 Million | -535.08 Million |
| Other non-cash items | -95.32 Million | -543.9 Million | 841.47 Million | 924.91 Million | 1.12 Billion | 948.99 Million |
| Investing Cash Flow | -4.77 Billion | -4.06 Billion | -3.85 Billion | -4.7 Billion | -171.96 Million | -5.24 Billion |
| Investments in PPE | -5.33 Billion | -5.88 Billion | -4.97 Billion | -4.43 Billion | -3.96 Billion | -3.17 Billion |
| Acquisitions | -924.19 Million | -487.56 Million | 381.43 Million | -140.33 Million | -818.78 Million | -622.58 Million |
| Investment purchases | -1.15 Billion | -1.5 Billion | -1.42 Billion | -1.07 Billion | -517.91 Million | -2.13 Billion |
| Sales/Maturities of investments | 2.72 Billion | 4.64 Billion | 2.16 Billion | 2.03 Billion | 4.91 Billion | 1.24 Billion |
| Other Investing Activities | -85.21 Million | -835.89 Million | -9.45 Million | -1.09 Billion | 210.62 Million | -557.39 Million |
| Financing Cash Flow | -1.32 Billion | 4.42 Billion | -831.27 Million | 1.46 Billion | -1.93 Billion | 3.13 Billion |
| Debt repayment | -1.72 Billion | -26.28 Billion | -27.39 Billion | -15.7 Billion | -13.94 Billion | -2.54 Billion |
| Dividends payments | -1.12 Billion | -1.43 Billion | -1.1 Billion | -1 Billion | -818.62 Million | -1.77 Billion |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | 4.85 Billion |
| Other Financing Activities | 1.51 Billion | 33.08 Billion | 28.47 Billion | 19 Billion | 13.87 Billion | 2.37 Billion |
| Accounts receivables | 1.6 Billion | -2.07 Billion | -1.79 Billion | -1.55 Billion | -863.27 Million | -661.59 Million |
| Accounts payables | -2.2 Billion | 2.3 Billion | 2.46 Billion | 1.52 Billion | 883.57 Million | 838.79 Million |
| Inventory | -333.9 Million | -1.43 Billion | -464.74 Million | -1.25 Billion | -505.18 Million | -564.69 Million |
| Other working capital | -1.00 | -188.49 Million | 52.75 Million | -116.61 Million | -9.68 Million | 29.61 Million |
| Cash at beginning of period | 11.4 Billion | 6.45 Billion | 7.32 Billion | 8.28 Billion | 7.17 Billion | 6.35 Billion |
| Cash at end of period | 9.75 Billion | 11.17 Billion | 6.45 Billion | 7.32 Billion | 8.28 Billion | 7.17 Billion |
| Capital Expenditure | -5.33 Billion | -5.88 Billion | -4.97 Billion | -4.43 Billion | -3.96 Billion | -3.17 Billion |
| Effect of forex changes on cash | 73.64 Million | 128.34 Million | -134.71 Million | -300.16 Million | -5.1 Million | -18.03 Million |
| Net cash flow / Change in cash | -1.64 Billion | 4.71 Billion | -874.23 Million | -959.48 Million | 1.1 Billion | 824.68 Million |
| Free Cash Flow | -973.42 Million | -1.67 Billion | -1.02 Billion | -1.85 Billion | -739.64 Million | -224.8 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 785.84 Million | 615.06 Million | 609.73 Million | 103.19 Million | 2.38 Billion | 505.59 Million |
| Depreciation & Amortization | - | 756.64 Million | 756.64 Million | 795.8 Million | 3.11 Billion | -1.45 Billion |
| Deferred income taxes | - | - | - | -1.3 Billion | -144.6 Million | 1.16 Billion |
| Stock-based compensation | - | - | - | 35.89 Million | 35.89 Million | -32.17 Million |
| Change in working capital | - | - | - | 1.27 Billion | -936.58 Million | -359.56 Million |
| Other non-cash items | 1.07 Billion | 1.22 Billion | 446.18 Million | 114.24 Million | -95.32 Million | 827.32 Million |
| Investing Cash Flow | 210.23 Million | -1.57 Billion | -1.21 Billion | -649.12 Million | -4.77 Billion | -922.26 Million |
| Investments in PPE | -933.59 Million | -838.9 Million | -1.25 Billion | -1.11 Billion | -5.33 Billion | -1.27 Billion |
| Acquisitions | 46.44 Million | -53.49 Million | 253.62 Million | 169.99 Million | -924.19 Million | -41.03 Million |
| Investment purchases | -293.68 Million | -976.7 Million | -37.18 Million | -468.01 Million | -1.15 Billion | -215.17 Million |
| Sales/Maturities of investments | 1.07 Billion | 90.04 Million | 19.39 Million | 1.75 Billion | 2.72 Billion | 986.13 Million |
| Other Investing Activities | 312.52 Million | 208.28 Million | -196.94 Million | -987.81 Million | -85.21 Million | -377.24 Million |
| Financing Cash Flow | -1.59 Billion | 1 Billion | -15.54 Million | -886.21 Million | -1.32 Billion | -1.79 Billion |
| Debt repayment | -207.31 Million | -1.71 Billion | -358.93 Million | -779.26 Million | -1.72 Billion | -4.68 Billion |
| Dividends payments | -1.03 Billion | -333.24 Million | -331.38 Million | -1.12 Billion | -1.12 Billion | -1.46 Billion |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -350.66 Million | -712.9 Million | -374.47 Million | 1.01 Billion | 1.51 Billion | 4.36 Billion |
| Accounts receivables | - | - | - | 1.6 Billion | 1.6 Billion | -1.02 Billion |
| Accounts payables | - | - | - | - | -2.2 Billion | - |
| Inventory | - | - | - | -333.9 Million | -333.9 Million | 660.68 Million |
| Other working capital | - | - | - | - | -1.00 | - |
| Cash at beginning of period | 9.86 Billion | 13 Billion | 9.75 Billion | 13.04 Billion | 11.4 Billion | 12.05 Billion |
| Cash at end of period | 9.47 Billion | 14.08 Billion | 13 Billion | 9.75 Billion | 9.75 Billion | 10.08 Billion |
| Capital Expenditure | -933.59 Million | -838.9 Million | -1.25 Billion | -1.11 Billion | -5.33 Billion | -1.27 Billion |
| Effect of forex changes on cash | -86.76 Million | -6.3 Million | 23.43 Million | -57.68 Million | 73.64 Million | 89.91 Million |
| Net cash flow / Change in cash | -389.75 Million | 1.07 Billion | 3.24 Billion | -3.28 Billion | -1.64 Billion | -1.97 Billion |
| Free Cash Flow | 929.57 Million | 247.89 Million | -198.53 Million | -105.95 Million | -973.42 Million | -623.3 Million |
VAN
VBIND
0309
BIM
002062
AGFY